AI assistant
Sending…
EKSO BIONICS HOLDINGS, INC. — Director's Dealing 2021
Aug 5, 2021
35095_dirs_2021-08-04_9bf1021b-0407-41d4-a86c-9bde6e4b6310.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EKSO BIONICS HOLDINGS, INC. (EKSO)
CIK: 0001549084
Period of Report: 2021-08-03
Reporting Person: Jones Jason C (VP of Product Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-03 | Common Stock | A | 50000 | $0.00 | Acquired | 71142 | Direct |
Footnotes
F1: Represents restricted stock units ("RSUs").
F2: The grant of RSUs was approved by the compensation committee of the board of directors on August 1, 2021.
F3: 1/3 of the total number of shares of Common Stock subject to the RSUs shall vest on August 30th of each year beginning 2022.
More from EKSO BIONICS HOLDINGS, INC.
Regulatory Filings
2026
Jun 4
Remuneration Information
2026
May 20
Annual Report
2026
Apr 10
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Proxy Solicitation & Information Statement
2026
Mar 20
Annual Report
2026
Feb 23
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 19
M&A Activity
2026
Feb 17